An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM

Clinical trial NCT06116968 · COMPLETED

Trial details

NCT number: NCT06116968
Sponsor: Corxel Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Obstructive Hypertrophic Cardiomyopathy

Start date: 2023-11-14
Primary completion: 2025-10-20
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.